Generic API researchSynthetic Molecules

12Years of

Omgene Life Sciences Private Limited, is a R&D based Biopharmaceutical Research Company, incorporated in March 2011 and is operating for around 12 years in bio pharmaceutical space, established by a highly skilled and experienced Technocrat working in Pharmaceutical field, Dr. AL. Prasad (MD), who leads the R&D team having around 30 years of industrial track-record and has a team of 90+ highly skilled workforce.

Since Inception, Omgene is a vertically integrated company, which has focused on producing Bio-pharmaceuticals, Peptides, Semi-synthetics and Synthetics Actives and formulation based on In-House produced actives. We are also producing and have commercialized number of Actives from our In-house GMP manufacturing facilities and through collaboration and in partnership with numerous Contract manufacturing facilities. We are also actively involved in formulation development of Injectables, Lyophilized injectable, complex generics and Solid oral and oral peptide delivery to provide affordable and high-quality medicines. Its always our commitment to innovate and deliver.

Dr. A.L. Prasad,
Founder CEO and MD
Omgene Life sciences Pvt. Ltd.

Why Choose Us

Focus on synthesis of complex API and its intermediates

  • Omgene is a Vadodara based R&D stage company engaged in development of lab-scale quantities of peptides, semi-synthetic & synthetic APIs and its intermediates
  • Expertise in synthesizing long peptide chains – up to 40 amino acid chains

Product development platform

  • 45 API/intermediates developed since inception and 13 under development;
  • Started work on formulation development across OSDs and lyophilised parenteral; currently 22 molecules across various stages of development
  • Cumulative spend on infra is INR 8002 mn / USD 11 mn

Backed by strong leadership and R&D staff

  • 5-member core leadership team brings +100 years of combined experience across pharma R&D, formulation development, etc.
  • 61 member R&D Team; 51 Masters and 5 PhD holders

Well-equipped R&D facility; tie up with CMOs for commercial quantity (large-scale) supplies

  • Well-equipped R&D facility; tie up with CMOs for commercial quantity (large-scale) supplies 20,000 sq.ft mg-to-kg scale setup
  • Added 3,000 sq.ft of cleanroom area for small volume API quantity supplies (GMP1)